Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era

  1. Scott J. Hultgren1,3
  1. 1Department of Molecular Microbiology and Microbial Pathogenesis, Washington University in Saint Louis School of Medicine, St. Louis, Missouri 63110-1010
  2. 2Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2363
  3. 3Center for Women’s Infectious Disease Research, Washington University in Saint Louis School of Medicine, St. Louis, Missouri 63110-1010
  1. Correspondence: hultgren{at}borcim.wustl.edu
  1. 4 These authors contributed equally to this work.

Abstract

Biofilm formation constitutes an alternative lifestyle in which microorganisms adopt a multicellular behavior that facilitates and/or prolongs survival in diverse environmental niches. Biofilms form on biotic and abiotic surfaces both in the environment and in the healthcare setting. In hospital wards, the formation of biofilms on vents and medical equipment enables pathogens to persist as reservoirs that can readily spread to patients. Inside the host, biofilms allow pathogens to subvert innate immune defenses and are thus associated with long-term persistence. Here we provide a general review of the steps leading to biofilm formation on surfaces and within eukaryotic cells, highlighting several medically important pathogens, and discuss recent advances on novel strategies aimed at biofilm prevention and/or dissolution.

Footnotes

  • 5 Present address: Monsanto Company, 800 N. Lindbergh Blvd., Saint Louis, Missouri 63167.

  • Editors: Pascale Cossart and Stanley Maloy

  • Additional Perspectives on Bacterial Pathogenesis available at www.perspectivesinmedicine.org

Also in this Collection

    | Table of Contents

    Richard Sever interviews Joan Brugge